[1] Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 2014;11(5):276 − 89. https://doi.org/10.1038/nrcardio.2014.26.
[2] Yang Y, Shi XZ, Jiang XY, Liu XC, Liu Y, Lu GL, et al. Analysis of the status and influencing factors of hypertension among Qingdao dock workers. Med J Commun 2003;(1):18-20. (In Chinese).
[3] Yang Y, Shi XZ, Jiang XY, Liu XC, Liu Y, Chi HJ, et al. Investigation on the prevalence of hypertension among Qingdao dock workers. Chin J Prev Control Chronic Dis 2000;8(6):282. http://qikan.cqvip.com/Qikan/Article/Detail?id=4806263&from=Qikan_Search_Index. (In Chinese).
[4] Wang JG. Chinese guidelines for the prevention and treatment of hypertension (2024 revision). J Geriatr Cardiol 2025;22(1):1 − 149. https://doi.org/10.26599/1671-5411.2025.01.008.
[5] R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. https://cran.r-project.org/doc/manuals/r-release/fullrefman.pdf.[2025-06-10].
[6] World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization, 2021. https://www.who.int/publications/i/item/9789240033986. [2025-06-10].
[7] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet 2021;398(10304):957 − 80. https://doi.org/10.1016/S0140-6736(21)01330-1.